Clinical trial
Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age
NCT01985997 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age
- Lead sponsor
- MedImmune LLC
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- July 31, 2014
- Enrollment
- 95,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
observation safety